Grifols (GIFLF) Dividends Paid - Common (2013 - 2025)
Grifols' (GIFLF) quarterly Dividends Paid - Common came in at -$149.0 million in Q4 2025, down 13843.31% on a YoY basis from N/an in Q4 2024, and down 13843.31% quarter-over-quarter from -$1.1 million in Q4 2024.
Analysis
Grifols (GIFLF) Dividends Paid - Common (2013 - 2025) Analysis & Trends
Grifols (GIFLF) has reported Dividends Paid - Common for 10 consecutive years, with -$149.0 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Dividends Paid - Common fell 13843.31% year-over-year to -$149.0 million; the trailing twelve-month figure through Dec 2025 stood at -$248.7 million (down 521.39% YoY), and the FY2025 full-year result was -$144.6 million, down 13433.26% from the prior year.
- Dividends Paid - Common eased to -$149.0 million in Q4 2025 per GIFLF's latest filing, from -$1.1 million in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $10.3 million in Q4 2022 and bottomed at -$149.0 million in Q4 2025.
- Historically, Dividends Paid - Common has averaged -$46.6 million across 3 years, with a median of -$1.1 million in 2024.
- The widest YoY moves for Dividends Paid - Common: up 13843.31% in 2025, down 13843.31% in 2025.
- Over 3 years, Dividends Paid - Common stood at $10.3 million in 2022, then slumped by 110.34% to -$1.1 million in 2024, then slumped by 13843.31% to -$149.0 million in 2025.
- According to Business Quant data, Dividends Paid - Common over the past three periods registered -$149.0 million, -$1.1 million, and $10.3 million for Q4 2025, Q4 2024, and Q4 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 1.36 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 1.03 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 96.80 Mn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | - |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | -149.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -149.00 Mn |
| Dec 31, 2024 | -1.07 Mn |
| Dec 31, 2022 | 10.33 Mn |
| Dec 31, 2019 | -108.94 Mn |
| Dec 31, 2018 | 158.70 Mn |
| Dec 31, 2017 | 112.18 Mn |
| Dec 31, 2016 | -132.71 Mn |
| Sep 30, 2016 | -208.15 Mn |
| Dec 31, 2015 | -355.06 Mn |
| Dec 31, 2014 | 107.42 Mn |
| Dec 31, 2013 | -1,361.09 |
| Sep 30, 2013 | 1,325.04 |